Acumen Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acumen Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Acumen Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -24.6 %, a 2.84% increase year-over-year.
  • Acumen Pharmaceuticals, Inc. annual Return On Equity for 2023 was -23.4 %, a 10.3% decline from 2022.
  • Acumen Pharmaceuticals, Inc. annual Return On Equity for 2022 was -21.2 %, a 83.8% increase from 2021.
  • Acumen Pharmaceuticals, Inc. annual Return On Equity for 2021 was -131 %, a 392% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -24.6 +0.72 +2.84% Apr 1, 2024 Jun 30, 2024
Q1 2024 -22.9 +0.49 +2.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -23.4 -2.19 -10.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.9 -5.7 -31.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -25.4 -11 -77.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -23.4 +34.9 +59.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21.2 +110 +83.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -18.2 Jul 1, 2022 Sep 30, 2022
Q2 2022 -14.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -58.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -131 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.